Status:
UNKNOWN
To Investigate the Efficacy and Mechanism of ZBP Powder Product in the Treatment of Osteopenia in Patients With Pain.
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Osteopenia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study investigates the efficacy and mechanism of traditional Chinese medicine formula power product in the treatment of osteopenia in patients with pain. Half of participants will receive Chinese...
Detailed Description
Osteoporosis is a major public health problem, resulting in potentially pain and increasing risk of fracture. Treatment of osteoporosis consists of pharmacotherapy, lifestyle measures, dietary changes...
Eligibility Criteria
Inclusion
- aged 50 years or older.
- VAS score≧4.0 in a week.
- bone mineral density (BMD) of all participants was -2.5 or below.
Exclusion
- diabetes.
- thyroidism function disorder.
- parathyroidism function disorder.
- liver or kidney function disorder.
- ovariectomy
- rheumatoid arthritis.
- bone cancer.
- ever used hormone agent within 6 months before assignment to treatment.
- ever used steroids more than 3 months before assignment to treatment.
- ever used analgesics, excepted acetaminophen, more than 1 week before assignment to treatment.
Key Trial Info
Start Date :
February 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 7 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03245710
Start Date
February 8 2017
End Date
March 7 2021
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WanFangH
Taipei, Taiwan, 116